Elite in Non-Small Cell Lung Cancer (NSCLC)

Dr. Tithi Biswas

Radiation Oncology
Florida Clinical Practice Association Inc
1600 Sw Archer Rd, 
Gainesville, FL 
Clinical Trials:Currently Recruiting for 2 Trials
Accepting New Patients
Elite in Non-Small Cell Lung Cancer (NSCLC)
Florida Clinical Practice Association Inc
1600 Sw Archer Rd, 
Gainesville, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Tithi Biswas is a Radiation Oncologist in Gainesville, Florida. Dr. Biswas is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Pleuropulmonary Blastoma. Dr. Biswas is currently accepting new patients.

Her clinical research consists of co-authoring 79 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 28 articles and participated in 5 clinical trials in the study of Non-Small Cell Lung Cancer (NSCLC).

Specialties
Radiation Oncology
Licenses
Radiology in NC
Hospital Affiliations
Uf Health Shands Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Florida Blue
  • EPO
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medical Health
  • HMO
  • PPO
Medical Mutual
  • HMO
  • PPO
Sunshine Health
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

FLORIDA CLINICAL PRACTICE ASSOCIATION INC
1600 Sw Archer Rd, Gainesville, FL 32610
Other Locations
FLORIDA CLINICAL PRACTICE ASSOCIATION INC
1549 Gale Lemerand Dr, Fl 4, Gainesville, FL 32610
FLORIDA CLINICAL PRACTICE ASSOCIATION INC
2001 Sw 13th St, Gi Clinic At Endoscopy Cen, Gainesville, FL 32608

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Phase 2 Randomized Study of the BER Inhibitor TRC102 in Combination With Standard Pemetrexed-Platinum-Radiation in Stage III Non-Squamous Non-Small Cell Lung Cancer
A Phase 2 Randomized Study of the BER Inhibitor TRC102 in Combination With Standard Pemetrexed-Platinum-Radiation in Stage III Non-Squamous Non-Small Cell Lung Cancer
Enrollment Status: Recruiting
Publish Date: October 15, 2025
Intervention Type: Drug, Procedure, Biological, Radiation
Study Drugs: Cisplatin, Durvalumab, Methoxyamine, Pemetrexed
Study Phase: Phase 2
MRI Brain Surveillance Alone Versus MRI Surveillance and Prophylactic Cranial Irradiation (PCI): A Randomized Phase III Trial in Small-Cell Lung Cancer (MAVERICK)
MRI Brain Surveillance Alone Versus MRI Surveillance and Prophylactic Cranial Irradiation (PCI): A Randomized Phase III Trial in Small-Cell Lung Cancer (MAVERICK)
Enrollment Status: Recruiting
Publish Date: May 25, 2025
Intervention Type: Procedure, Radiation
Study Phase: Phase 3
Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab
Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab
Enrollment Status: Active_not_recruiting
Publish Date: September 02, 2025
Intervention Type: Other, Drug, Radiation, Procedure
Study Drugs: Atezolizumab, Carboplatin, Cisplatin, Etoposide
Study Phase: Phase 3
Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial
Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial
Enrollment Status: Active_not_recruiting
Publish Date: March 11, 2025
Intervention Type: Radiation, Drug
Study Drugs: Docetaxel, Gemcitabine, Pemetrexed Disodium, Erlotinib Hydrochloride, Pembrolizumab
Study Phase: Phase 2
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 17, 2024
Intervention Type: Radiation
Study Phase: Phase 2/Phase 3
GRECO-1: Phase I/II, Randomized, Placebo-Controlled Study of Stereotactic Body Radiation Therapy (SBRT) and GC4711 for Centrally Located or Large, Node-Negative Non-Small Cell Lung Cancer (NSCLC)
GRECO-1: Phase I/II, Randomized, Placebo-Controlled Study of Stereotactic Body Radiation Therapy (SBRT) and GC4711 for Centrally Located or Large, Node-Negative Non-Small Cell Lung Cancer (NSCLC)
Enrollment Status: Terminated
Publish Date: April 30, 2024
Intervention Type: Drug
Study Drug: GC4711
Study Phase: Phase 1/Phase 2
A Pilot Trial of Proton Based Cardiac Sparing Accelerated Fractionated RadioTherapy in Unresectable Non-Small Cell Lung Cancer With Extended Durvalumab Therapy (PARTICLE-D)
A Pilot Trial of Proton Based Cardiac Sparing Accelerated Fractionated RadioTherapy in Unresectable Non-Small Cell Lung Cancer With Extended Durvalumab Therapy (PARTICLE-D)
Enrollment Status: Terminated
Publish Date: February 15, 2024
Intervention Type: Drug, Radiation
Study Drug: Durvalumab
Study Phase: Early Phase 1
A Phase I Study of Methoxyamine Combined With Chemo-Radiation for Locally Advanced Non-Squamous Non-Small Cell Lung Cancer
A Phase I Study of Methoxyamine Combined With Chemo-Radiation for Locally Advanced Non-Squamous Non-Small Cell Lung Cancer
Enrollment Status: Completed
Publish Date: June 30, 2022
Intervention Type: Drug, Radiation
Study Drugs: Cisplatin, Methoxyamine, Methoxyamine Hydrochloride, Pemetrexed, Pemetrexed Disodium
Study Phase: Phase 1
View 6 Less Clinical Trials

79 Total Publications

Torso Synthetic CT generation by integrating Deep Learning and Segmentation for FDG-PET/MR attenuation correction.
Torso Synthetic CT generation by integrating Deep Learning and Segmentation for FDG-PET/MR attenuation correction.
Journal: Biomedical physics & engineering express
Published: October 16, 2025
Similar Doctors
Advanced in Non-Small Cell Lung Cancer (NSCLC)
Dr. Michael R. Olson
Radiation Oncology | Radiology
Advanced in Non-Small Cell Lung Cancer (NSCLC)
Dr. Michael R. Olson
Radiation Oncology | Radiology

Baptist MD Anderson Cancer Physicians Inc

1301 Palm Ave, 
Jacksonville, FL 
 (61.8 miles away)
904-202-7300
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Michael Olson is a Radiation Oncologist and a Radiologist in Jacksonville, Florida. Dr. Olson is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Posterior Fossa Tumor, Lung Cancer, Pleuropulmonary Blastoma, and Astrocytoma. Dr. Olson is currently accepting new patients.

Advanced in Non-Small Cell Lung Cancer (NSCLC)
Dr. Mark E. Augspurger
Radiation Oncology
Advanced in Non-Small Cell Lung Cancer (NSCLC)
Dr. Mark E. Augspurger
Radiation Oncology

Baptist MD Anderson Cancer Physicians Inc

1301 Palm Ave, 
Jacksonville, FL 
 (61.8 miles away)
904-202-7300
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Mark Augspurger is a Radiation Oncologist in Jacksonville, Florida. Dr. Augspurger is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Lung Cancer, Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), and Pleuropulmonary Blastoma. Dr. Augspurger is currently accepting new patients.

Advanced in Non-Small Cell Lung Cancer (NSCLC)
Dr. Paul B. Ossi
Radiation Oncology
Advanced in Non-Small Cell Lung Cancer (NSCLC)
Dr. Paul B. Ossi
Radiation Oncology

Ackerman Cancer Center PA

10881 San Jose Blvd, 
Jacksonville, FL 
 (56.8 miles away)
904-260-3022
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Paul Ossi is a Radiation Oncologist in Jacksonville, Florida. Dr. Ossi is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Intraductal Papilloma, Breast Cancer, Pleuropulmonary Blastoma, and Lung Cancer. Dr. Ossi is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Biswas's expertise for a condition
ConditionClose
View All 7 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile